New insights into the global burden of noroviruses and opportunities for prevention
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

New insights into the global burden of noroviruses and opportunities for prevention
Filetype[PDF-282.45 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 4.17 MB]
    Personal Author:
    Lopman, Benjamin A.
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Bill & Melinda Gates Foundation.. CDC Foundation..
    Published Date:
    August 2015
    Description:
    The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention, or the US Department of Health and Human Services.This work was funded in p...
    File Type:
    Filetype[PDF - 4.17 MB]
  2. Filetype[PDF - 1.86 MB]
    Personal Author:
    Kowalzik, Frank; Binder, Harald; Zöller, Daniela; Riera-Montes, Margarita; Clemens, Ralf; Verstraeten, Thomas; Zepp, Fred;
    Published Date:
    November 2018
    Source:
    Emerg Infect Dis. 24(11):2021-2028
    Description:
    We estimated numbers of hospitalizations for norovirus gastroenteritis (NGE) and associated medical costs in Germany, where norovirus testing is high because reimbursement is affected. We extracted aggregate data for patients hospitalized with a prim...
    File Type:
    Filetype[PDF - 1.86 MB]
  3. Filetype[PDF - 109.96 KB]
    Personal Author:
    Aliabadi, Negar; Lopman, Ben A; Parashar, Umesh D; Hall, Aron J;
    Published Date:
    July 29 2015
    Source:
    Expert Rev Vaccines. 14(9):1241-1253
    Description:
    Human norovirus infection causes significant medical and financial costs in the USA and abroad. Some populations, including young children, the elderly, and the immunocompromised, are at heightened risk of infection with this virus and subsequent com...
    File Type:
    Filetype[PDF - 109.96 KB]
  4. Filetype[PDF - 79.10 KB]
    Personal Author:
    Immergluck, Lilly Cheng; Parker, Trisha Chan; Jain, Shabnam; Laghaie, Elham; Spandorfer, Philip; Jerris, Robert C.; Bowen, Michael D.; Parashar, Umesh D.; Cortese, Margaret M.;
    Published Date:
    Feb 28 2016
    Source:
    J Pediatr. 172:116-120.e1.
    Description:
    ObjectiveUsing case-control methodology, we measured the vaccine effectiveness (VE) of the 2-dose monovalent rotavirus vaccine (RV1) and 3-dose pentavalent vaccine (RV5) series given in infancy against rotavirus disease resulting in hospital emergenc...
    File Type:
    Filetype[PDF - 79.10 KB]
  5. Filetype[PDF - 958.05 KB]
    Personal Author:
    Yen, Catherine; Tate, Jacqueline E.; Hyde, Terri B.; Cortese, Margaret M.; Lopman, Benjamin A.; Jiang, Baoming; Glass, Roger I.; Parashar, Umesh D.;
    Published Date:
    Apr 22 2014
    Source:
    Hum Vaccin Immunother. 10(6):1436-1448.
    Description:
    Rotavirus is the leading cause of severe diarrhea among children<5 years worldwide. Currently licensed rotavirus vaccines have been efficacious and effective, with many countries reporting substantial declines in diarrheal and rotavirus-specific morb...
    File Type:
    Filetype[PDF - 958.05 KB]